Off the wire
• Urgent: NASA suspends 2016 launch of Mars lander due to instrument leak  • Chicago grains, soybeans show weakness ahead of Christmas holiday  • Urgent: U.S. dollar declines on profit-taking, negative data  • Latvia to set up workgroup to coordinate China-CEE cooperation events in 2016  • 1st LD Writethru: U.S. oil price rises amid light holiday trading  • S. Africa tourism remains flat in festive season  • Kenya's Garissa University to re-open in January  • Croatian president to name PM-designate or call an early election on Wednesday  • Feature: Prophet's Birthday high season for Egyptian pastry shops  • Feature: Egypt marks solar phenomenon at Luxor's Karnak Temple to promote tourism  
You are here: 　 Home

White House releases plan to fight multidrug-resistant tuberculosis

Xinhua, December 23, 2015 Adjust font size:

The White House on Tuesday released a plan to combat what it called a "global rise" of multidrug-resistant tuberculosis (MDR-TB).

The National Action Plan identified actions the U.S. government will take in the next three or five years, including ensuring that all patients with TB are promptly detected and treated and that people in close contact with such patients are identified, monitored, and if necessary, treated.

"Although any transmission of TB is of public health importance, an outbreak sparked by an individual with undiagnosed MDR-TB or XDR-TB (extensively drug-resistant TB) could have serious consequences due to the difficulty and costs associated with treating patients infected with these resistant strains," according to a statement released by the White House.

The plan also included a goal of improving international capacity and collaboration to combat the disease, which will be done through "strategic investments" to broaden access to diagnosis and treatment in the most affected communities.

In addition, the White House called for accelerating research to combat MDR-TB, including developing rapid tests to diagnose TB, novel therapies and drug regimens to cure TB and MDR-TB within weeks, and new vaccines with the potential to prevent all forms of TB.

TB has caused more deaths than any other single infectious disease worldwide, killing more than 1.5 million people each year, the White House said.

Each year, more than 9.5 million people develop active TB and about 480,000 people develop MDR-TB each year. However, fewer than 20 percent of individuals with MDR-TB receive the drugs they need to combat the disease and of them, less than half are cured.

The toll of TB on the global economy is estimated to be 12 billion U.S. dollars each year. In countries with a high-prevalence of TB, the disease is estimated to decrease gross domestic product by four to seven percent.

In the United States, it costs about 17,000 dollars to treat a patient with drug-susceptible TB, 150,000 dollars to treat a single patient with MDR-TB, and 482,000 dollars to treat a single patient with XDR-TB. Enditem